Stocks · Health care · Biological Products, (No Diagnostic Substances)

Kyverna Therapeutics, Inc.

KYTX Clue Score44
United States Fiscal year ends December CIK 0001994702 Results filed 11 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Karen Marie Walker
6 Jun 2024
Chief Technology Officer
Exercised, kept
9,636
$4.42
$42.59K
Ryan Alexander Jones
28 May 2024
Chief Financial Officer
Exercised, kept
7,146
$0.73
$5.22K
Ryan Alexander Jones
28 May 2024
Chief Financial Officer
Exercised, kept
10,870
$0.73
$7.94K

What was left out

Form 4 filings counted 41
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 27,194,442
History held since 12 Feb 2024